Veraxa Biotech Holding AG (VRXA) Net Cash Flow (2025)
Veraxa Biotech Holding AG (VRXA) posted Net Cash Flow of $126368.1 for Q4 2025.
Veraxa Biotech Holding AG (VRXA) Net Cash Flow (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Net Cash Flow for 1 consecutive years, with $126368.1 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 126,368.15 |
| Dec 31, 2025 | 126,368.15 |